Cheng, M.; Lee, H.H.; Chang, W.-H.; Lee, N.-R.; Huang, H.-Y.; Chen, Y.-J.; Horng, H.-C.; Lee, W.-L.; Wang, P.-H.
Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Int. J. Environ. Res. Public Health 2019, 16, 4794.
https://doi.org/10.3390/ijerph16234794
AMA Style
Cheng M, Lee HH, Chang W-H, Lee N-R, Huang H-Y, Chen Y-J, Horng H-C, Lee W-L, Wang P-H.
Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. International Journal of Environmental Research and Public Health. 2019; 16(23):4794.
https://doi.org/10.3390/ijerph16234794
Chicago/Turabian Style
Cheng, Min, Howard Hao Lee, Wen-Hsun Chang, Na-Rong Lee, Hsin-Yi Huang, Yi-Jen Chen, Huann-Cheng Horng, Wen-Ling Lee, and Peng-Hui Wang.
2019. "Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer" International Journal of Environmental Research and Public Health 16, no. 23: 4794.
https://doi.org/10.3390/ijerph16234794
APA Style
Cheng, M., Lee, H. H., Chang, W.-H., Lee, N.-R., Huang, H.-Y., Chen, Y.-J., Horng, H.-C., Lee, W.-L., & Wang, P.-H.
(2019). Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. International Journal of Environmental Research and Public Health, 16(23), 4794.
https://doi.org/10.3390/ijerph16234794
